Skip to main content

Table 1 Demographic and clinical characteristics of patients

From: Bowel preparation using 2-L split-dose polyethylene glycol regimen plus lubiprostone versus 4-L split-dose polyethylene glycol regimen: a randomized controlled trial

Variable

Total

(N = 140)

2 L PEG + LB

(n = 70)

4 L PEG

(n = 70)

p-value

Age, mean (SD)

58.7 (10.8)

58.8 (11.2)

58.5 (10.6)

0.85

Male sex, n (%)

84 (60.0)

44 (62.9)

40 (57.1)

0.49

BMI (kg/m2), mean (SD)

23.3 (4.2)

22.6 (4.1)

23.9 (4.3)

0.08

Education level, n (%)

   

0.20

 None

3 (2.1)

3 (4.3)

0 (0)

 

 Below Bachelor’s degree

92 (65.7)

44 (62.9)

48 (68.6)

 

 Bachelor’s degree or higher

45 (32.2)

23 (32.8)

22 (31.4)

 

Underlying diseases, n (%)

    

 None

46 (32.9)

22 (31.4)

24 (34.3)

0.70

 Hypertension

43 (30.7)

21 (30.0)

22 (31.4)

0.86

 Dyslipidemia

29 (20.7)

15 (21.4)

14 (20.0)

0.84

 Diabetes mellitus

24 (17.1)

11 (15.7)

13 (18.6)

0.65

 Cardiovascular

11 (7.9)

8 (11.4)

3 (4.3)

0.12

 Other

20 (14.3)

9 (12.9)

11 (15.7)

0.63

Laxative use, n (%)

32 (22.9)

17 (24.3)

15 (21.4)

0.69

Previous colonoscopy, n (%)

53 (37.9)

25 (35.7)

28 (40.0)

0.60

Indication for colonoscopy, n (%)

    

 Colorectal cancer screening

45 (32.2)

23 (32.9)

22 (31.4)

0.86

 Abdominal pain

27 (19.3)

10 (14.3)

17 (24.3)

0.13

 Bowel habit change

15 (10.7)

11 (15.7)

4 (5.7)

0.10

 History of colonic polyps

12 (8.6)

7 (10.0)

5 (7.2)

0.55

 Lower GI bleeding

12 (8.6)

4 (5.7)

8 (11.4)

0.22

 Chronic diarrhea

9 (6.4)

5 (7.1)

4 (5.7)

0.73

 Iron deficiency anemia

8 (5.7)

3 (4.3)

5 (7.2)

0.72

 Significant weight loss

5 (3.6)

4 (5.7)

1 (1.4)

0.37

 Positive fecal occult blood test

3 (2.1)

0 (0)

3 (4.3)

0.25

 Abnormal CT finding

2 (1.4)

2 (2.9)

0 (0)

0.50

 Other

2 (1.4)

1 (1.4)

1 (1.4)

0.99